Y4W-26288-75215
3 vaccinations
3 coded responses
13 check-ins
3 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 132 / NY
- Registered
- 2021-10-12
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-16
Dose 1 — Pfizer-BioNTech
-
2021-04-06
Dose 2 — Pfizer-BioNTech
-
2021-10-10
Dose 3 — Pfizer-BioNTech
-
2021-10-12
Registered in v-safe
- 2021-10-12
-
2021-10-13
Survey response — days 1–6 daily, dose 3MedDRA: Injection site pain — Feeling: GoodFree text: My arm was sore at the site for the first two days but that was it.MedDRA releases: 2024-11 · check-in free text available
- 2021-10-14
- 2021-10-15
- 2021-10-16
- 2021-10-17
- 2021-10-24
- 2021-10-31
-
2021-11-07
Survey response — day 28, dose 3MedDRA: Unevaluable event — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visitFree text: I have a possible placental abruption or venous lakeMedDRA releases: 2024-11 · check-in free text available
-
2021-11-07
Report sent to call center — day 28, dose 3Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalEmergency room or emergency department visit · 1 call case(s)
-
2021-11-09
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
- 2021-11-14
- 2021-11-21
- 2022-01-11
-
2022-04-10
Survey response — 6 months, dose 3MedDRA: Caesarean section, Foetal-maternal haemorrhage — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, HospitalizationFree text: I had a fetal maternal hemmorhage that resulted in an emergency cesarean at 33 weeks and 4 daysMedDRA releases: 2024-11 · check-in free text available
-
2022-04-10
Report sent to call center — 6 months, dose 3Be unable to work or attend school · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · Hospitalization · 1 call case(s)
-
2022-04-11
Call successfulParticipant prefers to complete VAERS report online
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-16 | Pfizer-BioNTech | No |
| 2 | 2021-04-06 | Pfizer-BioNTech | No |
| 3 | 2021-10-10 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-11-07 | Successful 2021-11-09 |
Not applicable (accidental reporting or does not believe symptoms are related to vaccine) |
| 2022-04-10 | Successful 2022-04-11 |
Participant prefers to complete VAERS report online |
Free text
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): My arm was sore at the site for the first two days but that was it.
Release 10 — day 28, dose 3
Symptoms: I have a possible placental abruption or venous lake
Release 11 — 6 months, dose 3
Symptoms: I had a fetal maternal hemmorhage that resulted in an emergency cesarean at 33 weeks and 4 days
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Caesarean section | · | · | ✓ |
| SD | Foetal-maternal haemorrhage | · | · | ✓ |
| SD | Unevaluable event | · | · | ✓ |
| SRO | Injection site pain | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release